New Hope For Later Stage Prostate Cancer Patients: The PARP Inhibitor Olaparib Approved By The FDA

Updated October 18th, 2021

New Hope For Later Stage Prostate Cancer Patients: The PARP Inhibitor Olaparib Approved By The FDA

The FDA has approved PARP Inhibitor Olaparib for the treatment of advanced prostate cancer patients. Experts say this approval marks new personalized therapy options for specific tumors.

NOW
PLAYING
5 Tips on How to Use Cannabis For Cancer
NOW
PLAYING
It’s National Breast Cancer Awareness Month; Here Are Four Treatment & Screening Advancements Grabbing the Attention of Oncologists
NOW
PLAYING
'Star Trek' Actor William Shatner Is Living His Best Life and Just Became the Oldest Person to Fly to Space after a Prostate Cancer Misdiagnosis in 2016
NOW
PLAYING
Philanthropist John Ingram Had His Prostate Removed To Prevent Cancer
NOW
PLAYING
Trouble in Bed, Decreased Penis Length ... the Difficult Prostate Cancer Treatment Side Effects Doctors May Not Highlight
NOW
PLAYING
A Survivor With a Prostate Cancer Awareness Ribbon Tattoo Is Determined to Educate and Help Others Dealing with the Disease
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.